Overall Status

Completed (1)

Not yet recruiting (1)

Terminated (1)

Sign in for free

Phase

n/a (1)

phase 1/phase 2 (1)

Sponsor

Genetron Health (1)

Nuvation Bio Inc. (1)

Virginia Commonwealth University (1)

Collaborator

American Psychological Foundation (1)

Huashan Hospital (1)

The First Hospital of Jilin University (1)

West China Hospital (1)

Zhejiang University (1)

Intervention

c-smart (1)

nuv-422 (1)

Study Documents

Intervention Type

behavioral (1)

drug (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

glioma, mixed

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glioma, Mixed, Mild Neurocognitive Disorder Trial (C-SMART)

Not yet recruiting

Glioma, Mixed
Mild Neurocognitive Disorder

C-SMART

(no location specified)

Aug 11, 2023

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated

Glioma
+23 more

NUV-422

Tucson, Arizona
+11 more

Sep 30, 2022

Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients

Completed

Glioma, Malignant
Glioma, Mixed

Jilin, China
+3 more

Nov 12, 2021